Executive Vice President, Finance and Managing Director of Seed Funds
Nora Doherty joined BioCrossroads in 2003 after working many years with entrepreneurial companies. She serves as Executive Vice President of Finance and Managing Director of Seed Funds. In this role, she directs activities of nearly $24M assets under management for use in early stage investment in life sciences companies having completed investments in over two dozen companies including SonarMed, Calibrium, Assembly (ASMB), Anagin, and Scioto Biosciences. Doherty has also overseen many BioCrossroads research and publications including Advancing Indiana’s Life Sciences Competitive and Strategic Collaborations; Impact of Talent on Innovation: Indy’s Talent Dynamics; and Impact of Research Institutions on Regional Economies, among others.
Doherty has a history of working for entrepreneurial companies. She was vice president of Electronic Evolutions and a co-founder, vice president of Operations and vice president Legal, Human Resources and Administration, and corporate secretary with Escient Technologies. Escient Technologies managed numerous consumer electronic and internet related businesses, including Gracenote® which was purchased by Sony in 2008.
Doherty received her BA and MBA from Indiana University, where she was a member of the honors program. She also received the “Excellence in Leadership” award as special recognition from the professors and administration of Indiana University MBA-CIP for leadership and contribution to the program.